

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.58168498 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.57414650 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.44159946 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.36852844 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35846029 |
| 6 | response to muramyl dipeptide (GO:0032495) | 4.16036983 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.10819569 |
| 8 | response to peptidoglycan (GO:0032494) | 4.08874067 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.06147563 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.06147563 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.06147563 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.06147563 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.06147563 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.06147563 |
| 15 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.02637824 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.95271958 |
| 17 | positive regulation of heat generation (GO:0031652) | 3.91518996 |
| 18 | myeloid dendritic cell activation (GO:0001773) | 3.80837455 |
| 19 | myeloid dendritic cell differentiation (GO:0043011) | 3.80075467 |
| 20 | regulation of fever generation (GO:0031620) | 3.77803478 |
| 21 | positive regulation of interferon-alpha production (GO:0032727) | 3.77027012 |
| 22 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.76440182 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.69038752 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.69038752 |
| 25 | positive regulation of interleukin-12 production (GO:0032735) | 3.65537544 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.65381103 |
| 27 | response to type I interferon (GO:0034340) | 3.64950450 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.64463893 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.58590462 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 3.58556220 |
| 31 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.57702384 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 3.51975695 |
| 33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.48497162 |
| 34 | granulocyte activation (GO:0036230) | 3.47970325 |
| 35 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44713093 |
| 36 | neutrophil activation (GO:0042119) | 3.43806558 |
| 37 | regulation of vitamin metabolic process (GO:0030656) | 3.43715841 |
| 38 | positive regulation of isotype switching (GO:0045830) | 3.39132440 |
| 39 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.38035195 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37781425 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37518381 |
| 42 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37518381 |
| 43 | defense response to protozoan (GO:0042832) | 3.31628049 |
| 44 | germinal center formation (GO:0002467) | 3.31509761 |
| 45 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.29405638 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.28884730 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 3.26708841 |
| 48 | positive regulation of acute inflammatory response (GO:0002675) | 3.22543378 |
| 49 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.21438533 |
| 50 | regulation of podosome assembly (GO:0071801) | 3.19390353 |
| 51 | regulation of T-helper cell differentiation (GO:0045622) | 3.19164885 |
| 52 | regulation of RIG-I signaling pathway (GO:0039535) | 3.18911060 |
| 53 | positive regulation of interleukin-17 production (GO:0032740) | 3.18404900 |
| 54 | positive regulation of mast cell degranulation (GO:0043306) | 3.17973502 |
| 55 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.17973502 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.17850484 |
| 57 | response to protozoan (GO:0001562) | 3.17297683 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17261692 |
| 59 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.16937853 |
| 60 | positive regulation of B cell mediated immunity (GO:0002714) | 3.16674529 |
| 61 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.16674529 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15593629 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 3.14725526 |
| 64 | positive regulation of type 2 immune response (GO:0002830) | 3.14002734 |
| 65 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13773929 |
| 66 | interferon-gamma production (GO:0032609) | 3.12200131 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.12084636 |
| 68 | T cell migration (GO:0072678) | 3.10976266 |
| 69 | negative regulation of growth of symbiont in host (GO:0044130) | 3.10827760 |
| 70 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.10827760 |
| 71 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.10827760 |
| 72 | regulation of growth of symbiont in host (GO:0044126) | 3.10827760 |
| 73 | regulation of interleukin-12 production (GO:0032655) | 3.10477816 |
| 74 | positive regulation of humoral immune response (GO:0002922) | 3.10465364 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08487294 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 3.07959084 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07527543 |
| 78 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07149175 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.06783064 |
| 80 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.06723274 |
| 81 | detection of other organism (GO:0098543) | 3.05921528 |
| 82 | regulation of immunoglobulin secretion (GO:0051023) | 3.05252375 |
| 83 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.05184239 |
| 84 | regulation of hypersensitivity (GO:0002883) | 3.04886379 |
| 85 | leukocyte aggregation (GO:0070486) | 3.04816302 |
| 86 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.04405060 |
| 87 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.04306865 |
| 88 | regulation of interleukin-17 production (GO:0032660) | 3.03784270 |
| 89 | regulation of mast cell activation (GO:0033003) | 3.03011140 |
| 90 | positive regulation of interleukin-10 production (GO:0032733) | 3.02810351 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.00851856 |
| 92 | regulation of germinal center formation (GO:0002634) | 2.99730361 |
| 93 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98561910 |
| 94 | regulation of heat generation (GO:0031650) | 2.96834482 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 2.96819221 |
| 96 | regulation of antigen processing and presentation (GO:0002577) | 2.96661613 |
| 97 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.96142920 |
| 98 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.95997408 |
| 99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.95855380 |
| 100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.95649178 |
| 101 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95583031 |
| 102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.95325696 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.95137017 |
| 104 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.94675907 |
| 105 | regulation of response to interferon-gamma (GO:0060330) | 2.93757100 |
| 106 | positive regulation of DNA recombination (GO:0045911) | 2.93121653 |
| 107 | response to interleukin-15 (GO:0070672) | 2.92766431 |
| 108 | positive regulation of interleukin-2 production (GO:0032743) | 2.89513972 |
| 109 | natural killer cell mediated immunity (GO:0002228) | 2.88569775 |
| 110 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.88569775 |
| 111 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87701335 |
| 112 | negative regulation of cell killing (GO:0031342) | 2.87701335 |
| 113 | negative thymic T cell selection (GO:0045060) | 2.87372891 |
| 114 | dendritic cell differentiation (GO:0097028) | 2.87060479 |
| 115 | detection of bacterium (GO:0016045) | 2.86739833 |
| 116 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.84840420 |
| 117 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84585753 |
| 118 | negative regulation of interleukin-17 production (GO:0032700) | 2.84425232 |
| 119 | macrophage activation (GO:0042116) | 2.84281960 |
| 120 | mature B cell differentiation involved in immune response (GO:0002313) | 2.83719558 |
| 121 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.82908471 |
| 122 | cellular extravasation (GO:0045123) | 2.82741458 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82407388 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80054325 |
| 125 | response to host immune response (GO:0052572) | 2.80054325 |
| 126 | negative T cell selection (GO:0043383) | 2.79871076 |
| 127 | cytokine secretion (GO:0050663) | 2.79529424 |
| 128 | T cell activation involved in immune response (GO:0002286) | 2.78458519 |
| 129 | T-helper 1 type immune response (GO:0042088) | 2.78011503 |
| 130 | dendritic cell chemotaxis (GO:0002407) | 2.77950050 |
| 131 | cellular response to zinc ion (GO:0071294) | 2.77276097 |
| 132 | positive regulation of interferon-beta production (GO:0032728) | 2.76465241 |
| 133 | microglial cell activation (GO:0001774) | 2.76376359 |
| 134 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.76055866 |
| 135 | natural killer cell activation (GO:0030101) | 2.75863795 |
| 136 | respiratory burst (GO:0045730) | 2.75784740 |
| 137 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.75645753 |
| 138 | positive regulation of B cell differentiation (GO:0045579) | 2.75429412 |
| 139 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73239713 |
| 140 | negative regulation of lipid storage (GO:0010888) | 2.73147690 |
| 141 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.73135791 |
| 142 | myeloid leukocyte activation (GO:0002274) | 2.73114072 |
| 143 | regulation of natural killer cell differentiation (GO:0032823) | 2.72241393 |
| 144 | regulation of B cell differentiation (GO:0045577) | 2.69528198 |
| 145 | response to interferon-alpha (GO:0035455) | 2.69513739 |
| 146 | B cell mediated immunity (GO:0019724) | 2.69220336 |
| 147 | positive thymic T cell selection (GO:0045059) | 2.69090505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.18297611 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.83409737 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.54890814 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.09206771 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.49616037 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.25364626 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.17770207 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.77196794 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.48244381 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.44076980 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38447854 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13223907 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.05416374 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.98123677 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.89930777 |
| 16 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.76179838 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.67220449 |
| 18 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64725000 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63188522 |
| 20 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.59260066 |
| 21 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58107368 |
| 22 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51091444 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.50606504 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17848708 |
| 25 | * MYB_26560356_Chip-Seq_TH2_Human | 2.12556955 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 1.94278362 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.89080357 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88533991 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78687265 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78032054 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76727062 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.75102512 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.68531908 |
| 34 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58677529 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58173723 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57908720 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56065121 |
| 38 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48852881 |
| 39 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47776959 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47519994 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46147055 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45314234 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40445221 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40071635 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.38584607 |
| 46 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.36981323 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28519544 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.28030770 |
| 49 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27742510 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25876685 |
| 51 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21837234 |
| 52 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.16544614 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16532869 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15287967 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13945437 |
| 56 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.12480178 |
| 57 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12034331 |
| 58 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12034331 |
| 59 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11056218 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09676186 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09512250 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08158966 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07761975 |
| 64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06853488 |
| 65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06847540 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05608860 |
| 67 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04152434 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01263254 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00932305 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96425225 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96012966 |
| 72 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95893057 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95283813 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94730006 |
| 75 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94640592 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94346713 |
| 77 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93102351 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 0.92313702 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92095569 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91903492 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91135490 |
| 82 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89056788 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88101091 |
| 84 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.87135376 |
| 85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85752506 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83521061 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82940838 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82882596 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82872922 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82124595 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81539405 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81278232 |
| 93 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81028085 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80826536 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79037527 |
| 96 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.77365070 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77210568 |
| 98 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76978047 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76972901 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75770264 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75640773 |
| 102 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75542634 |
| 103 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.73902161 |
| 104 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73317780 |
| 105 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73248048 |
| 106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71713865 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71327142 |
| 108 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.71084371 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69691605 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69367487 |
| 111 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.69136589 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68148529 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.67956652 |
| 114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.67644103 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67560993 |
| 116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65527599 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63979259 |
| 118 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63380063 |
| 119 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63338514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.50532548 |
| 2 | MP0000685_abnormal_immune_system | 3.70550452 |
| 3 | MP0009785_altered_susceptibility_to | 3.45598218 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.37805795 |
| 5 | MP0003436_decreased_susceptibility_to | 3.36623862 |
| 6 | MP0005671_abnormal_response_to | 3.26992397 |
| 7 | MP0005387_immune_system_phenotype | 3.23059831 |
| 8 | MP0001790_abnormal_immune_system | 3.23059831 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.18865956 |
| 10 | * MP0001800_abnormal_humoral_immune | 3.06734589 |
| 11 | MP0003724_increased_susceptibility_to | 3.06217028 |
| 12 | MP0006082_CNS_inflammation | 2.79771236 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.79456562 |
| 14 | MP0004510_myositis | 2.77258227 |
| 15 | MP0002419_abnormal_innate_immunity | 2.75129101 |
| 16 | * MP0005025_abnormal_response_to | 2.71108036 |
| 17 | * MP0002723_abnormal_immune_serum | 2.68303835 |
| 18 | * MP0001819_abnormal_immune_cell | 2.39848696 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.38778560 |
| 20 | MP0004947_skin_inflammation | 2.37523745 |
| 21 | MP0003303_peritoneal_inflammation | 2.23108865 |
| 22 | MP0002405_respiratory_system_inflammati | 2.17468927 |
| 23 | MP0001853_heart_inflammation | 2.08514025 |
| 24 | MP0002006_tumorigenesis | 2.03650750 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.93058076 |
| 26 | MP0008004_abnormal_stomach_pH | 1.87369911 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.86608327 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.84407744 |
| 29 | * MP0010155_abnormal_intestine_physiology | 1.82527259 |
| 30 | * MP0002398_abnormal_bone_marrow | 1.80102292 |
| 31 | * MP0000716_abnormal_immune_system | 1.78968969 |
| 32 | * MP0001845_abnormal_inflammatory_respons | 1.78939342 |
| 33 | MP0002254_reproductive_system_inflammat | 1.75580275 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.74210449 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.67242396 |
| 36 | MP0001851_eye_inflammation | 1.62157196 |
| 37 | MP0009764_decreased_sensitivity_to | 1.60284516 |
| 38 | MP0003448_altered_tumor_morphology | 1.60251674 |
| 39 | MP0001873_stomach_inflammation | 1.58768576 |
| 40 | MP0005310_abnormal_salivary_gland | 1.58042829 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.56216140 |
| 42 | MP0008469_abnormal_protein_level | 1.44512275 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.44274208 |
| 44 | * MP0002429_abnormal_blood_cell | 1.42242932 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.41293042 |
| 46 | MP0004381_abnormal_hair_follicle | 1.40534911 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.40440699 |
| 48 | MP0000858_altered_metastatic_potential | 1.40299153 |
| 49 | MP0005451_abnormal_body_composition | 1.38768107 |
| 50 | MP0002722_abnormal_immune_system | 1.35990069 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.30940571 |
| 52 | MP0003453_abnormal_keratinocyte_physiol | 1.27693761 |
| 53 | MP0009278_abnormal_bone_marrow | 1.25771067 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.23511163 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.23288744 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.21226860 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.14050710 |
| 58 | MP0002009_preneoplasia | 1.13994152 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.12193150 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.10418632 |
| 61 | MP0003195_calcinosis | 1.09232422 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.08867913 |
| 63 | MP0009840_abnormal_foam_cell | 1.07870368 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.07374080 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.07096982 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.06568308 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.05082264 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.01858249 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.01421507 |
| 70 | MP0000343_altered_response_to | 1.00475625 |
| 71 | MP0002933_joint_inflammation | 0.99919276 |
| 72 | MP0005390_skeleton_phenotype | 0.99255253 |
| 73 | MP0006054_spinal_hemorrhage | 0.98917215 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.98481243 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.98481243 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.97328463 |
| 77 | MP0005164_abnormal_response_to | 0.96169734 |
| 78 | MP0003045_fibrosis | 0.95878851 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.94233496 |
| 80 | MP0003828_pulmonary_edema | 0.93266908 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 0.90371409 |
| 82 | MP0002132_abnormal_respiratory_system | 0.90144934 |
| 83 | MP0003075_altered_response_to | 0.87893190 |
| 84 | MP0003646_muscle_fatigue | 0.87586199 |
| 85 | MP0001216_abnormal_epidermal_layer | 0.85435161 |
| 86 | MP0003866_abnormal_defecation | 0.85312967 |
| 87 | MP0005166_decreased_susceptibility_to | 0.85273841 |
| 88 | MP0001663_abnormal_digestive_system | 0.83808915 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.82343255 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.80933852 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.80381033 |
| 92 | MP0000627_abnormal_mammary_gland | 0.76878557 |
| 93 | MP0010307_abnormal_tumor_latency | 0.76729291 |
| 94 | MP0005275_abnormal_skin_tensile | 0.76675587 |
| 95 | MP0002060_abnormal_skin_morphology | 0.76395672 |
| 96 | MP0009763_increased_sensitivity_to | 0.76177943 |
| 97 | MP0005165_increased_susceptibility_to | 0.75735523 |
| 98 | MP0000249_abnormal_blood_vessel | 0.75140298 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.75019687 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.73825219 |
| 101 | MP0001881_abnormal_mammary_gland | 0.73268857 |
| 102 | MP0003091_abnormal_cell_migration | 0.73106805 |
| 103 | MP0005023_abnormal_wound_healing | 0.72541749 |
| 104 | MP0002163_abnormal_gland_morphology | 0.72183495 |
| 105 | MP0001501_abnormal_sleep_pattern | 0.71723957 |
| 106 | MP0005535_abnormal_body_temperature | 0.71586400 |
| 107 | MP0003690_abnormal_glial_cell | 0.71082993 |
| 108 | MP0004883_abnormal_blood_vessel | 0.71060888 |
| 109 | MP0000371_diluted_coat_color | 0.70893897 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.70150888 |
| 111 | MP0000604_amyloidosis | 0.69284297 |
| 112 | MP0001191_abnormal_skin_condition | 0.68144332 |
| 113 | MP0003186_abnormal_redox_activity | 0.67769009 |
| 114 | MP0005647_abnormal_sex_gland | 0.66597720 |
| 115 | MP0001542_abnormal_bone_strength | 0.66106060 |
| 116 | MP0001879_abnormal_lymphatic_vessel | 0.65536568 |
| 117 | MP0002796_impaired_skin_barrier | 0.65144582 |
| 118 | MP0003795_abnormal_bone_structure | 0.63463382 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.62942076 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.54091644 |
| 121 | MP0000609_abnormal_liver_physiology | 0.51913470 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.49514039 |
| 123 | MP0008874_decreased_physiological_sensi | 0.48012975 |
| 124 | MP0008873_increased_physiological_sensi | 0.45930110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.26338822 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.71907562 |
| 3 | Myositis (HP:0100614) | 5.55183114 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.51449683 |
| 5 | Optic neuritis (HP:0100653) | 5.44774298 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.44774298 |
| 7 | Orchitis (HP:0100796) | 5.41546591 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.77388061 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.62489777 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.24838857 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.24838857 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.24838857 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.95833219 |
| 14 | Increased IgM level (HP:0003496) | 3.92028817 |
| 15 | Stomatitis (HP:0010280) | 3.91285117 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.90739346 |
| 17 | Vasculitis (HP:0002633) | 3.80949636 |
| 18 | Pulmonary infiltrates (HP:0002113) | 3.66101420 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.63612127 |
| 20 | Recurrent skin infections (HP:0001581) | 3.56267756 |
| 21 | Recurrent viral infections (HP:0004429) | 3.46315831 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.39053450 |
| 23 | Arterial thrombosis (HP:0004420) | 3.31148913 |
| 24 | Gingivitis (HP:0000230) | 3.22949897 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.20454436 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.16618465 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.13980683 |
| 28 | Cellulitis (HP:0100658) | 3.10847988 |
| 29 | Meningitis (HP:0001287) | 3.09348495 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.07831159 |
| 31 | Thick nail (HP:0001805) | 3.05795308 |
| 32 | Obstructive lung disease (HP:0006536) | 2.98348751 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98348751 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 2.97304547 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.91635988 |
| 36 | Periodontitis (HP:0000704) | 2.88900080 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85936706 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85936706 |
| 39 | Nasal polyposis (HP:0100582) | 2.84266916 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.83837469 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.81149998 |
| 42 | Chronic otitis media (HP:0000389) | 2.79653888 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 2.78104609 |
| 44 | Pustule (HP:0200039) | 2.78084939 |
| 45 | Loss of speech (HP:0002371) | 2.78017048 |
| 46 | Increased IgE level (HP:0003212) | 2.72064706 |
| 47 | Polyneuropathy (HP:0001271) | 2.70698982 |
| 48 | Hemoptysis (HP:0002105) | 2.67913435 |
| 49 | Disinhibition (HP:0000734) | 2.66730349 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.63312150 |
| 51 | Amyloidosis (HP:0011034) | 2.62118815 |
| 52 | Colitis (HP:0002583) | 2.62022306 |
| 53 | Leukocytosis (HP:0001974) | 2.61461445 |
| 54 | Abnormality of B cell number (HP:0010975) | 2.60836196 |
| 55 | Gangrene (HP:0100758) | 2.60747199 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.60647976 |
| 57 | IgA deficiency (HP:0002720) | 2.59821037 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59301327 |
| 59 | T lymphocytopenia (HP:0005403) | 2.58575088 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.58173382 |
| 61 | Abnormality of the nasal mucosa (HP:0000433) | 2.57864894 |
| 62 | Basal ganglia calcification (HP:0002135) | 2.56574156 |
| 63 | Chronic diarrhea (HP:0002028) | 2.55910109 |
| 64 | Increased serum ferritin (HP:0003281) | 2.54081057 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.52944648 |
| 66 | Prostate neoplasm (HP:0100787) | 2.52279948 |
| 67 | Eosinophilia (HP:0001880) | 2.50235449 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.47175529 |
| 69 | Encephalitis (HP:0002383) | 2.43297562 |
| 70 | Episodic fever (HP:0001954) | 2.43231814 |
| 71 | Vertigo (HP:0002321) | 2.42548372 |
| 72 | Osteomyelitis (HP:0002754) | 2.41770701 |
| 73 | B lymphocytopenia (HP:0010976) | 2.41407724 |
| 74 | Abnormality of T cells (HP:0002843) | 2.39656922 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.37639501 |
| 76 | Gingival bleeding (HP:0000225) | 2.36509899 |
| 77 | Petechiae (HP:0000967) | 2.36266556 |
| 78 | Recurrent pneumonia (HP:0006532) | 2.35612150 |
| 79 | Osteolytic defects of the hand bones (HP:0009699) | 2.34521572 |
| 80 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34521572 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.30056068 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29727174 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29727174 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29727174 |
| 85 | Porencephaly (HP:0002132) | 2.29429801 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.29140622 |
| 87 | Myocardial infarction (HP:0001658) | 2.28946269 |
| 88 | Urticaria (HP:0001025) | 2.25230953 |
| 89 | Keratitis (HP:0000491) | 2.23947110 |
| 90 | Anorexia (HP:0002039) | 2.23259309 |
| 91 | Purpura (HP:0000979) | 2.21607738 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 2.21405690 |
| 93 | Premature loss of primary teeth (HP:0006323) | 2.20284194 |
| 94 | Hematochezia (HP:0002573) | 2.20272659 |
| 95 | Joint swelling (HP:0001386) | 2.19512867 |
| 96 | Abnormality of the pericardium (HP:0001697) | 2.18832722 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18787798 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.18787798 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.18358365 |
| 100 | Amaurosis fugax (HP:0100576) | 2.18218564 |
| 101 | Abnormality of the pleura (HP:0002103) | 2.17951619 |
| 102 | Restrictive lung disease (HP:0002091) | 2.16579629 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 2.15962460 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 2.15332082 |
| 105 | Abnormality of T cell physiology (HP:0011840) | 2.15228367 |
| 106 | Persistence of primary teeth (HP:0006335) | 2.13245774 |
| 107 | Abnormality of eosinophils (HP:0001879) | 2.12419546 |
| 108 | IgM deficiency (HP:0002850) | 2.12187275 |
| 109 | Thrombocytosis (HP:0001894) | 2.12063881 |
| 110 | Granulocytopenia (HP:0001913) | 2.10177464 |
| 111 | IgG deficiency (HP:0004315) | 2.08682831 |
| 112 | Recurrent lower respiratory tract infections (HP:0002783) | 2.07030772 |
| 113 | Skin ulcer (HP:0200042) | 1.99833275 |
| 114 | Pulmonary embolism (HP:0002204) | 1.98009501 |
| 115 | Glomerulopathy (HP:0100820) | 1.96966096 |
| 116 | Emphysema (HP:0002097) | 1.94736963 |
| 117 | Sepsis (HP:0100806) | 1.94002612 |
| 118 | Peritonitis (HP:0002586) | 1.93582635 |
| 119 | Epistaxis (HP:0000421) | 1.93468802 |
| 120 | Abnormality of the prostate (HP:0008775) | 1.92739527 |
| 121 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92002030 |
| 122 | Arthralgia (HP:0002829) | 1.91586058 |
| 123 | Chest pain (HP:0100749) | 1.90882990 |
| 124 | Lymphopenia (HP:0001888) | 1.90239437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.94297754 |
| 2 | MAP4K1 | 3.13216443 |
| 3 | TBK1 | 3.12889873 |
| 4 | TYK2 | 3.06738072 |
| 5 | TXK | 3.02210054 |
| 6 | IKBKE | 3.00694657 |
| 7 | IRAK4 | 2.90201197 |
| 8 | * IKBKB | 2.78948650 |
| 9 | JAK3 | 2.74291299 |
| 10 | RIPK4 | 2.42732826 |
| 11 | BLK | 2.39522175 |
| 12 | IRAK3 | 2.34333246 |
| 13 | JAK1 | 2.17017338 |
| 14 | CHUK | 2.06376913 |
| 15 | EPHA3 | 1.98010500 |
| 16 | TAOK2 | 1.95713832 |
| 17 | ITK | 1.87505835 |
| 18 | MAP3K13 | 1.86245941 |
| 19 | EPHB1 | 1.83629439 |
| 20 | PIM2 | 1.77398199 |
| 21 | TGFBR2 | 1.76687852 |
| 22 | PRPF4B | 1.75556084 |
| 23 | STK10 | 1.71025248 |
| 24 | ZAP70 | 1.68714548 |
| 25 | FGFR4 | 1.65860304 |
| 26 | IRAK1 | 1.63267779 |
| 27 | KIT | 1.51290433 |
| 28 | FGFR3 | 1.50986632 |
| 29 | ERN1 | 1.48783260 |
| 30 | TLK1 | 1.44754335 |
| 31 | MST4 | 1.44370759 |
| 32 | DMPK | 1.43264356 |
| 33 | NME2 | 1.40945207 |
| 34 | TEC | 1.40124207 |
| 35 | CSK | 1.36525120 |
| 36 | HCK | 1.33548442 |
| 37 | PIM1 | 1.32957863 |
| 38 | BTK | 1.31802228 |
| 39 | SYK | 1.29718506 |
| 40 | TAOK1 | 1.25724445 |
| 41 | DDR2 | 1.20709851 |
| 42 | MAP3K11 | 1.15386220 |
| 43 | NLK | 1.13922039 |
| 44 | CSF1R | 1.11140533 |
| 45 | MAP3K3 | 1.08315724 |
| 46 | JAK2 | 1.07221244 |
| 47 | LCK | 1.06153529 |
| 48 | NEK9 | 1.02907747 |
| 49 | STK24 | 1.01232371 |
| 50 | ADRBK2 | 0.99148588 |
| 51 | GSK3A | 0.96199372 |
| 52 | GRK7 | 0.94917162 |
| 53 | MARK3 | 0.93807576 |
| 54 | EIF2AK2 | 0.91125809 |
| 55 | TNK2 | 0.91105252 |
| 56 | IRAK2 | 0.90077206 |
| 57 | MAPK15 | 0.89172623 |
| 58 | RPS6KA4 | 0.84644573 |
| 59 | CDC42BPA | 0.82837211 |
| 60 | LYN | 0.82719270 |
| 61 | MAP3K5 | 0.78781890 |
| 62 | MAP2K3 | 0.74897664 |
| 63 | LRRK2 | 0.74547349 |
| 64 | BMX | 0.72403070 |
| 65 | PTK6 | 0.71619867 |
| 66 | SIK3 | 0.71209793 |
| 67 | TAOK3 | 0.68077987 |
| 68 | NUAK1 | 0.65576627 |
| 69 | STK4 | 0.64341418 |
| 70 | RIPK1 | 0.63428733 |
| 71 | PRKCQ | 0.62476136 |
| 72 | CDK9 | 0.62396474 |
| 73 | MAPKAPK2 | 0.61657878 |
| 74 | MAP3K12 | 0.61449902 |
| 75 | TESK2 | 0.60630780 |
| 76 | HIPK2 | 0.58659741 |
| 77 | TRPM7 | 0.57881695 |
| 78 | STK3 | 0.57611798 |
| 79 | FES | 0.57085354 |
| 80 | MST1R | 0.56773257 |
| 81 | BMPR1B | 0.56514430 |
| 82 | PDK1 | 0.52589787 |
| 83 | MAP2K6 | 0.51516482 |
| 84 | PBK | 0.51297170 |
| 85 | CDK6 | 0.50447349 |
| 86 | ABL1 | 0.48523190 |
| 87 | CLK1 | 0.47900890 |
| 88 | ABL2 | 0.46328709 |
| 89 | PRKCD | 0.45589363 |
| 90 | EIF2AK3 | 0.45336654 |
| 91 | MAPK4 | 0.44812507 |
| 92 | MAP3K10 | 0.43662625 |
| 93 | FLT3 | 0.41792870 |
| 94 | GRK6 | 0.41169935 |
| 95 | PDPK1 | 0.41088173 |
| 96 | PDGFRB | 0.40945286 |
| 97 | PKN1 | 0.40553069 |
| 98 | EGFR | 0.40159254 |
| 99 | TGFBR1 | 0.38092499 |
| 100 | RPS6KA5 | 0.37382440 |
| 101 | CDK12 | 0.36897276 |
| 102 | NEK6 | 0.36584793 |
| 103 | MAPK12 | 0.36497243 |
| 104 | KDR | 0.35623416 |
| 105 | IGF1R | 0.35572902 |
| 106 | FGR | 0.35245073 |
| 107 | MATK | 0.35122688 |
| 108 | YES1 | 0.34845610 |
| 109 | MOS | 0.32828803 |
| 110 | FYN | 0.32808167 |
| 111 | MAP3K1 | 0.32529227 |
| 112 | ARAF | 0.31685169 |
| 113 | PIK3CA | 0.31336110 |
| 114 | RPS6KA1 | 0.30606508 |
| 115 | MAPK3 | 0.29882174 |
| 116 | ERBB3 | 0.29829424 |
| 117 | CDK19 | 0.28831957 |
| 118 | SIK2 | 0.28794250 |
| 119 | RPS6KA6 | 0.27400338 |
| 120 | SGK3 | 0.26961874 |
| 121 | DAPK3 | 0.26820393 |
| 122 | MAPK11 | 0.26687640 |
| 123 | CDK4 | 0.26633212 |
| 124 | MAPK7 | 0.26332358 |
| 125 | RPS6KL1 | 0.25181750 |
| 126 | RPS6KC1 | 0.25181750 |
| 127 | INSR | 0.24473847 |
| 128 | MAP2K2 | 0.23427252 |
| 129 | PIK3CG | 0.23197199 |
| 130 | PDK2 | 0.22876064 |
| 131 | * BMPR2 | 0.21848280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.88412437 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.46715926 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.02201870 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.97032473 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.91389953 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.49770125 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46492470 |
| 8 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42718523 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.33189081 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.31661490 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.17739161 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13584320 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.11190476 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.06387200 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02358082 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.02139574 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.00755142 |
| 18 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.99571210 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.90285485 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.85619475 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84362516 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.82663755 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78772231 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77379280 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76880583 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.74734799 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74532708 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.72475185 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.71386776 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61912587 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.60256604 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.55717147 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53311571 |
| 34 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52904152 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49366229 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45636968 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37814662 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30267510 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.27514859 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19984663 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.18115696 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.07393197 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02435994 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.01530777 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96926024 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95402953 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.92402517 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90521922 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88809961 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87397926 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86286772 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.81879869 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79975595 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77347798 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76928849 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74001996 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71434566 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.69601699 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.69380701 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66456016 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62850678 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59838163 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59082512 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58880240 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57386321 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56113683 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51841477 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45412023 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41685879 |
| 70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41544716 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38741308 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38526867 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.38513491 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.38295883 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37847469 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36233089 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35890983 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33503949 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32694882 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32471277 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32195167 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.31567335 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30424882 |
| 84 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28157830 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26067536 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25398411 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.24633178 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.23710257 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23668809 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21176186 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21071577 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20724894 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19806426 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.19549622 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18726066 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.18435413 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.17574490 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17388626 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.16658145 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16278358 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14719401 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.14138327 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14000515 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12461124 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12119210 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.10426740 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.09559284 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08954240 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.07941433 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07641607 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05278240 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01734332 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.00035614 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0168608 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0005822 |

